Rapid Dose Therapeutics Corp.

DOSE.CNCNQHealthcare● Active

$0.10

$-0.01(-5.00%)

Market Cap$12529265

P/E Ratio—

52W High$0.24

52W Low$0.085

Avg Volume108K

Open$0.10

Beta-0.65

Overview

Rapid Dose Therapeutics Corp. (DOSE.CN) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

DOSE.CN · earnings · updated Jun 8, 2026

Latest Earnings

Q1 FY2026Report Date: Jan 27, 2026

EPS Actual

-$0.01

Revenue

$0.00B

Fiscal Period

Q1 FY2026

FY ends December

Report Date

Jan 27, 2026

After Market Close

DOSE.CN reports quarterly as a CNQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Rev. $0.58B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

Rev. Est.$0.58B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q1 FY2026	Jan 27, 2026	—	-$0.01	—	$0.00B	—	—
— Q4 FY2025	Oct 28, 2025	—	-$0.01	—	$0.00B	—	—
— Q2 FY2025	Jun 30, 2025	—	-$0.01	—	$0.00B	—	—
— Q1 FY2025	Jan 29, 2025	—	-$0.01	—	$0.00B	—	—
— Q1 FY2025	Jan 27, 2025	—	-$0.01	—	$0.00B	—	—
— Q3 FY2024	Aug 28, 2024	—	-$0.01	—	$0.00B	—	—
— Q3 FY2024	Jul 26, 2024	—	-$0.01	—	$0.00B	—	—
— Q1 FY2024	Jan 29, 2024	—	-$0.02	—	$0.00B	—	—

Q1 FY2026

Jan 27, 2026

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2025

Oct 28, 2025

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2025

Jun 30, 2025

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2025

Jan 29, 2025

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2025

Jan 27, 2025

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q3 FY2024

Aug 28, 2024

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q3 FY2024

Jul 26, 2024

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2024

Jan 29, 2024

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for DOSE.CN.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q1 FY2026	Jan 27, 2026	—	$0.14	$0.14	+0.00%
— Q4 FY2025	Oct 28, 2025	—	$0.16	$0.16	+0.00%
— Q2 FY2025	Jun 30, 2025	—	$0.21	$0.19	-11.90%
— Q1 FY2025	Jan 29, 2025	—	$0.21	$0.21	+0.00%
— Q1 FY2025	Jan 27, 2025	—	$0.20	$0.21	+2.50%
— Q3 FY2024	Aug 28, 2024	—	$0.14	$0.15	+11.11%
— Q3 FY2024	Jul 26, 2024	—	$0.18	$0.18	+0.00%
— Q1 FY2024	Jan 29, 2024	—	$0.16	$0.16	+0.00%

Q1 FY2026+0.00%

Report Date

Jan 27, 2026

EPS Beat/Miss

—

Price Before

$0.14

Price After

$0.14

Q4 FY2025+0.00%

Report Date

Oct 28, 2025

EPS Beat/Miss

—

Price Before

$0.16

Price After

$0.16

Q2 FY2025-11.90%

Report Date

Jun 30, 2025

EPS Beat/Miss

—

Price Before

$0.21

Price After

$0.19

Q1 FY2025+0.00%

Report Date

Jan 29, 2025

EPS Beat/Miss

—

Price Before

$0.21

Price After

$0.21

Q1 FY2025+2.50%

Report Date

Jan 27, 2025

EPS Beat/Miss

—

Price Before

$0.20

Price After

$0.21

Q3 FY2024+11.11%

Report Date

Aug 28, 2024

EPS Beat/Miss

—

Price Before

$0.14

Price After

$0.15

Q3 FY2024+0.00%

Report Date

Jul 26, 2024

EPS Beat/Miss

—

Price Before

$0.18

Price After

$0.18

Q1 FY2024+0.00%

Report Date

Jan 29, 2024

EPS Beat/Miss

—

Price Before

$0.16

Price After

$0.16

Beat Rate0 / 8 quarters

Largest Move-11.90% (Q2 FY2025)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Rapid Dose Therapeutics Corp. (DOSE.CN) most recently reported earnings on January 27, 2026 for Q1 FY2026, posting EPS of $-0.01 (in line with the analyst consensus of —). The next DOSE.CN earnings date is expected around September 1, 2026.

Each quarter, investors track DOSE.CN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DOSE.CN revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

DOSE.CN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

DOSE.CN earnings · 4 questions

Rapid Dose Therapeutics Corp.'s next earnings report is expected around September 1, 2026. DOSE.CN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DOSE.CN historically reports after market close (AMC).

DOSE.CN earnings datewhen is DOSE.CN earningsDOSE.CN next earnings datewhen does DOSE.CN report earningsDOSE.CN earnings calendar

▸ Source: FMP · Rapid Dose Therapeutics Corp. SEC filings · US GAAP · Rapid Dose Therapeutics Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026